GC
DNMR

Guggenheim Capital’s Danimer Scientific, Inc. DNMR Stock Holding History

Guggenheim Capital’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-386
Closed -$252K – 2251
2021
Q3 		$252K Sell
386
-70
-15% -$51.5K ﹤0.01% 1982
2021
Q2 		$457K Buy
+456
New +$455K ﹤0.01% 1867

Other funds holding DNMR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Heathbridge Capital Management Toronto, Ontario, Canada $292M AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TA
Teramo Advisors Naples, Florida $529M AUM 20.59% 1-Year Est. Return

Guggenheim Capital's DNMR Position: Q4 2021 in Review

Guggenheim Capital sold out of Danimer Scientific, Inc. (DNMR) in Q4 2021, closing a stake of 386 shares — an estimated $252K sold.

Guggenheim Capital first reported a position in DNMR in Q2 2021 and held it in 2 quarters. The position peaked at $457K in Q2 2021. 208 funds tracked by Wall St. Rank hold DNMR as of Q4 2021.

  • Guggenheim Capital reported no remaining Danimer Scientific, Inc. position as of Q4 2021 after selling out during the quarter.
  • Guggenheim Capital sold 386 Danimer Scientific, Inc. shares in Q4 2021, an estimated $252K.
  • Guggenheim Capital first reported a position in Danimer Scientific, Inc. in Q2 2021 and held it in 2 quarters.
  • Guggenheim Capital's Danimer Scientific, Inc. position peaked at $457K in Q2 2021.
  • 208 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2021.

Based on Guggenheim Capital's 13F filing for Q4 2021, filed 14 Feb 2022.